Gefitinib Stada

Gefitinib Stada is an oral medication used to treat certain types of cancer. This pharmaceutical is designed to target specific proteins involved in cancer cell growth.

Gefitinib Stada is primarily used in the treatment of non-small cell lung cancer (NSCLC). It works by inhibiting the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. Patients often wonder, 'What is Gefitinib used for?' This medication is typically prescribed for advanced or metastatic NSCLC that has specific EGFR mutations.

Common effects of Gefitinib Stada may include skin rash, diarrhea, and dry skin. Some users may also experience nausea, loss of appetite, or fatigue. These effects can vary in severity and may not affect everyone who takes the medication.

Gefitinib Stada should be handled with care and stored as directed. It is important to follow the advice of a healthcare professional regarding its use. Patients with certain medical conditions or allergies should inform their healthcare provider before starting this medication.

Gefitinib Stada may interact with other medications, including certain antibiotics, antifungals, and seizure medications. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Additionally, grapefruit and grapefruit juice should be avoided as they can affect how the body processes Gefitinib.